Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $37.3M
Founded date: 2016
Investors 4
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Reimagined... | reimagined... |
| - | Taiho Vent... | taihoventu... |
| - | OneVenture... | one-ventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.10.2021 | Series C | $37.3M | - |
Mentions in press and media 6
| Date | Title | Description |
| 10.02.2022 | The second fund of UTokyo Innovation Platform Co. comes to final closing with JPY25.6 billion, involving 11 institutional investors | TOKYO, Feb. 10, 2022 /PRNewswire/ -- We are pleased to announce that a fund operated by UTokyo Innovation Platform Co., Ltd. (UTokyo IPC), the venture investment arm of the University of Tokyo (UTokyo), Japan's leading national university, ... |
| 10.02.2022 | The second fund of UTokyo Innovation Platform Co. comes to final closing with JPY25.6 billion, involving 11 institutional investors | TOKYO, Feb. 9, 2022 /PRNewswire/ -- We are pleased to announce that a fund operated by UTokyo Innovation Platform Co., Ltd. (UTokyo IPC), the venture investment arm of the University of Tokyo (UTokyo), Japan's leading national university, h... |
| 14.10.2021 | Nextdoor CEO Sarah Friar throws down a gauntlet to social media companies—and to herself | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Social media is a double-edged sword full of unintended consequences, as recent election cycles a... |
| 14.10.2021 | Nextdoor CEO Sarah Friar throws down a gauntlet to social media companies—and to herself | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Social media is a double-edged sword full of unintended consequences, as recent election cycles a... |
| - | Axial Therapeutics Promotes A. Stewart Campbell to Chief Executive Officer | WOBURN, Mass.--(BUSINESS WIRE)--Mar 8, 2021-- Axial Therapeutics Inc., a clinical-stage biopharmaceutical company focused on leveraging the gut-brain axis for the discovery and development of small molecule therapeutics with an initial focu... |
| - | Investors have poured $548 million into neuroscience biotechs this year. Meet the 10 startups that have raised the most cash. | Peter Anastasiou, the CEO of Capsida Biotherapeutics. Capsida Biotherapeutics This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Neuroscience companies have raised more money from VCs in rec... |